A Bayesian Discrete Framework for Enhancing Decision-Making Processes in Clinical Trial Designs and Evaluations

📅 2026-01-15
📈 Citations: 1
Influential: 0
📄 PDF

career value

201K/year
🤖 AI Summary
This study addresses the limitations of conventional frequentist approaches in effectively incorporating prior knowledge, which constrains adaptive decision-making and reliability in clinical trials. The authors propose a Bayesian framework tailored for discrete probability distributions—such as binomial, Poisson, and negative binomial—to model binary responses and overdispersed clinical endpoints using Bayesian networks. By continuously integrating accumulating evidence, the framework dynamically optimizes trial design and evaluation. Compared to maximum likelihood estimation, this approach demonstrates greater flexibility and robustness in both inferential behavior and practical performance, substantially enhancing decision quality while mitigating misinterpretation of results and reproducibility challenges.

Technology Category

Application Category

📝 Abstract
This study examines the application of Bayesian approach in the context of clinical trials, emphasizing their increasing importance in contemporary biomedical research. While conventional frequentist approach provides a foundational basis for analysis, it often lacks the flexibility to integrate prior knowledge, which can constrain its effectiveness in adaptive settings. In contrast, Bayesian methods enable continual refinement of statistical inferences through the assimilation of accumulating evidence, thereby supporting more informed decision-making and improving the reliability of trial findings. This paper also considers persistent challenges in clinical investigations, including replication difficulties and the misinterpretation of statistical results, suggesting that Bayesian strategies may offer a path toward enhanced analytical robustness. Moreover, discrete probability models, specifically the Binomial, Poisson, and Negative Binomial distributions are explored for their suitability in modeling clinical endpoints, particularly in trials involving binary responses or data with overdispersion. The discussion further incorporates Bayesian networks and Bayesian estimation techniques, with a comparative evaluation against maximum likelihood estimation to elucidate differences in inferential behavior and practical implementation.
Problem

Research questions and friction points this paper is trying to address.

clinical trials
Bayesian methods
statistical inference
replication
decision-making
Innovation

Methods, ideas, or system contributions that make the work stand out.

Bayesian inference
discrete probability models
clinical trial design
Bayesian networks
adaptive decision-making
🔎 Similar Papers
No similar papers found.
P
Paramahansa Pramanik
Department of Mathematics and Statistics, University of South Alabama, 411 North University Boulevard, Mobile, AL 36688, USA.
A
Arnab K Maity
Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, CT 06877, USA.
A
Anjan Mandal
Department of Mathematical Sciences, University of Nevada, Las Vegas, 4505 S. Maryland Pkwy. Las Vegas, NV 89154, USA.
H
H. K. Robinson
Department of Biomedical Sciences, University of South Alabama, Mobile, Alabama 36688, USA.